NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma.

NIOX VERO® provides accurate and reliable results, allowing healthcare
professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, with a simple touch screen interface and intuitive design, and can be used in a variety of settings, including clinics, hospitals, and primary care settings.

The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX® is also committed to offering additional training and support for healthcare professionals.

Overall, NIOX Group plc is the global leader in FeNO testing, with a strong
reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO®, healthcare professionals have a reliable and non-invasive1 tool to help them better diagnose and manage asthma.

References:
1. Alving K et al. Pulm Ther. 2017;3:207-218.
2. Gao J et al. Allergy, Asthma & Clinical Immunology. 2018;1
3. Busse WW et al. Lancet Respir Med. 2021;9(10):1165-1173.
4. Menzies-Gow A et al. Eur Respir J. 2020;55(3):1901633.
5. NIOX® Data on File. MKT-DOF-006. 2023.

Health Care

Life Sciences

Medical Devices

FeNO by NIOX® USA

Org chart

Similar companies